Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

Phosphatidylinositol 3-kinase (PI3K) inhibitors & Non-Hodgkin lymphoma (NHL)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

Phosphatidylinositol-3-kinase (PI3K) inhibitors have shown activity in relapsed or refractory (R/R) indolent non-Hodgkin lymphoma (iNHL). PI3K inhibitors have been hampered by poor long-term tolerability and toxicity, which interfere with continuous use.
Fowler et al. 2021

…

References (Sources)

Current status of phosphoinotiside-3 kinase inhibitors in blood cancers
Shouse et al. 2022 Curr Opin Oncol 34: 540-545
Review
Umbralisib, a Dual PI3Kδ/CK1ε Inhibitor in Patients With Relapsed or Refractory Indolent Lymphoma
Fowler et al. 2021

AI Chat

7/1/2026

Chat with our artificial intelligence:

Start chat!

Phosphatidylinositol 3-kinase (PI3K) inhibitors & Non-Hodgkin lymphoma (NHL)

Welcome to meRfi Microbiome!

Navigation

Contents

References (Sources)

AI Chat